Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...